Singapore markets open in 6 hours 24 minutes

BioLine Rx Ltd (YP2.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
0.27000.0000 (0.00%)
At close: 08:14AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
11,655
4,800
0
0
0
Cost of revenue
5,147
3,692
0
0
-
Gross profit
6,508
1,108
0
0
-
Operating expenses
Research development
11,329
12,519
17,629
19,466
18,173
Selling general and administrative
33,786
31,230
11,489
5,269
4,684
Total operating expenses
45,466
44,100
29,157
24,777
22,927
Operating income or loss
-38,958
-42,992
-29,157
-24,777
-22,927
Interest expense
2,146
2,144
1,786
984
1,470
Total other income/expenses net
-10,055
-17,461
5,324
-1,548
-5,838
Income before tax
-49,149
-60,615
-24,951
-27,054
-30,021
Income from continuing operations
-49,149
-60,615
-24,951
-27,054
-30,021
Net income
-49,148
-60,614
-24,951
-27,054
-30,021
Net income available to common shareholders
-49,148
-60,614
-24,951
-27,054
-30,021
Basic EPS
-0.75
-0.90
-0.45
-0.60
-1.80
Diluted EPS
-0.75
-0.90
-0.45
-0.60
-1.80
Basic average shares
61,658
64,224
51,597
44,196
16,856
Diluted average shares
61,658
64,224
51,597
44,196
16,856